825-90-1 | Sodium 4-hydroxybenzenesulfonate

825-90-1    87001-32-9 

[1]OrganicandBiomolecularChemistry,2005,vol.3,#14,p.2513-2518

[2]EuropeanJournalofMedicinalChemistry,1991,vol.26,#4,p.403-413

[3]Patent:US2012/116072,2012,A1,

[4]Patent:US2012/323006,2012,A1,

[5]EuropeanJournalofMedicinalChemistry,2013,vol.62,p.379-394

[6]Patent:WO2014/29983,2014,A1,

[7]Patent:US2014/275108,2014,A1,

[8]JournalofMedicinalChemistry,2014,vol.57,#23,p.9971-9982

[9]ArchivderPharmazie,2017,vol.350,#1,

825-90-1    98995-40-5 

[1]BioorganicandMedicinalChemistry,2013,vol.21,#21,p.6466-6476

98-67-9    825-90-1 

[1]Patent:EP2035505,2016,B1,.Locationinpatent:Paragraph0184;0188

3885-04-9    825-90-1 

[1]JournalofOrganicChemistry,1996,vol.61,#5,p.1682-1688

[2]HelveticaChimicaActa,2003,vol.86,#4,p.1167-1174

108-95-2    825-90-1 

[1]JournalofOrganicChemistry,1996,vol.61,#20,p.6814-6817

825-90-1    4025-67-6 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/197370,2005,A1Locationinpatent:Page/Pagecolumn21

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/203064,2005,A1Locationinpatent:Page/Pagecolumn19

[3]CurrentPatentAssignee:EqtPartnersAB;Galderma(in:EQTPartners)-US2012/323006,2012,A1Locationinpatent:Page/Pagecolumn27

[4]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-US2014/275108,2014,A1Locationinpatent:Paragraph0356

[5]CurrentPatentAssignee:RESVERLOGIXCORP-WO2006/45010,2006,A2Locationinpatent:Page/Pagecolumn173

[6]Rolland,Catherine;Hanquet,Gilles;Ducep,Jean-Bernard;Solladié,Guy[TetrahedronLetters,2001,vol.42,#51,p.9077-9080]

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-US7138432,2006,B1Locationinpatent:Page/Pagecolumn38

[8]CurrentPatentAssignee:AUTOBAHNTHERAPEUTICS-EP1849773,2007,A1Locationinpatent:Page/Pagecolumn33

[9]Locationinpatent:experimentalpartHansen,HenrikC.;Chiacchia,FabrizioS.;Patel,Reena;Wong,NormanC.W.;Khlebnikov,Vladimir;Jankowska,Renata;Patel,Kalpesh;Reddy,M.Madhava[EuropeanJournalofMedicinalChemistry,2010,vol.45,#5,p.2018-2023]

[10]Li,Ya-Li;Qi,Xiang-Yu;Jiang,Hui;Deng,Xiao-Dong;Dong,Yan-Ping;Ding,Ting-Bo;Zhou,Lu;Men,Peng;Chu,Yong;Wang,Ren-Xiao;Jiang,Xian-Cheng;Ye,De-Yong[BioorganicandMedicinalChemistry,2015,vol.23,#18,p.6173-6184]

[11]CurrentPatentAssignee:FUDANUNIVERSITY-CN105439914,2016,ALocationinpatent:Paragraph0046;0047

[12]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-JP5914384,2016,B2Locationinpatent:Paragraph0166

[13]CurrentPatentAssignee:SCRIPPSRESEARCH-US10117840,2018,B2Locationinpatent:Page/Pagecolumn19;47;49

[14]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

[15]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-JP5914379,2016,B2Locationinpatent:Paragraph0143

[16]Chan,Michael;Lao,FitzgeraldS.;Chu,PaulJ.;Shpigelman,Jonathan;Yao,Shiyin;Nan,Jason;Sato-Kaneko,Fumi;Li,Vicky;Hayashi,Tomoko;Corr,Maripat;Carson,DennisA.;Cottam,HowardB.;Shukla,NikunjM.[JournalofMedicinalChemistry,2019,vol.62,#21,p.9521-9540]

[17]He,Tian-Jun;Huang,Jing-Mei;Zhong,Wei-Qiang[ChemicalCommunications,2020,vol.56,#18,p.2735-2738]

[18]CurrentPatentAssignee:NANJINGGEARPHARMATECH;SINOBIOPHARMACEUTICALLIMITED-EP3689860,2020,A1Locationinpatent:Page/Pagecolumn0184;0190

[19]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-WO2021/34729,2021,A1Locationinpatent:Page/Pagecolumn101

825-90-1    3355-28-0   

4-but-2-ynyloxy-benzenesulfonicacidsodiumsalt 

[1]CurrentPatentAssignee:PFIZERINC-EP1149074,2004,B1Locationinpatent:Page21

[2]CurrentPatentAssignee:PFIZERINC-US2003/208066,2003,A1Locationinpatent:Page/Pagecolumn18

[3]CurrentPatentAssignee:PFIZERINC-EP1147102,2004,B1Locationinpatent:Page24

[4]CurrentPatentAssignee:PFIZERINC-EP1144368,2004,B1Locationinpatent:Page41

[5]CurrentPatentAssignee:PFIZERINC-EP1144369,2004,B1Locationinpatent:Page36

[6]CurrentPatentAssignee:PFIZERINC-EP1147095,2004,B1Locationinpatent:Page81

[7]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-US2012/323006,2012,A1Locationinpatent:Page/Pagecolumn12-13

[8]CurrentPatentAssignee:Galderma(in:EQTPartners);EqtPartnersAB-US2014/275108,2014,A1Locationinpatent:Paragraph0203;0204

[9]CurrentPatentAssignee:PFIZERINC-EP1147085,2005,B1Locationinpatent:Page/Pagecolumn24;34;41

[10]Boiteau,Jean-Guy;Ouvry,Gilles;Arlabosse,Jean-Marie;Astri,Stéphanie;Beillard,Audrey;Bhurruth-Alcor,Yushma;Bonnary,Laetitia;Bouix-Peter,Claire;Bouquet,Karine;Bourotte,Marilyne;Cardinaud,Isabelle;Comino,Catherine;Deprez,Benoît;Duvert,Denis;Féret,Angélique;Hacini-Rachinel,Feriel;Harris,CraigS.;Luzy,Anne-Pascale;Mathieu,Arnaud;Millois,Corinne;Orsini,Nicolas;Pascau,Jonathan;Pinto,Artur;Piwnica,David;Polge,Gaëlle;Reitz,Arnaud;Reversé,Kevin;Rodeville,Nicolas;Rossio,Patricia;Spiesse,Delphine;Tabet,Samuel;Taquet,Nathalie;Tomas,Loïc;Vial,Emmanuel;Hennequin,LaurentF.[BioorganicandMedicinalChemistry,2018,vol.26,#4,p.945-956]

[11]Levin;Chen;Cheung;Cole;Crago;DelosSantos;Du;Khafizova;MacEwan;Niu;Salaski;Zask;Cummons;Sung;Xu;Zhang;Xu;Ayral-Kaloustian;Jin;Cowling;Barone;Mohler;Black;Skotnicki[BioorganicandMedicinalChemistryLetters,2003,vol.13,#16,p.2799-2803]

[12]CurrentPatentAssignee:PFIZERINC-US6544984,2003,B1

825-90-1    87001-32-9 

[1]OrganicandBiomolecularChemistry,2005,vol.3,p.2513-2518

[2]EuropeanJournalofMedicinalChemistry,1991,vol.26,p.403-413

[3]Patent:US2012/116072,2012,A1

[4]Patent:US2012/323006,2012,A1

[5]EuropeanJournalofMedicinalChemistry,2013,vol.62,p.379-394

[6]Patent:WO2014/29983,2014,A1

[7]Patent:US2014/275108,2014,A1

[8]JournalofMedicinalChemistry,2014,vol.57,p.9971-9982

[9]ArchivderPharmazie,2017,vol.350

825-90-1    150374-99-5 

[1]BioorganicandMedicinalChemistry,1996,vol.4,p.2115-2134

[2]Patent:JP5746484,2015,B2

[3]JournalofOrganicChemistry,2018,vol.83,p.4323-4335

825-90-1    127373-66-4 

[1]BioorganicandMedicinalChemistry,1996,vol.4,p.2115-2134

[2]Patent:JP5746484,2015,B2

[3]Patent:JP5746484,2015,B2